Peroxisome Proliferator-activated Receptor Gamma Concentrations in Newly Diagnosed Hypertension Patients and the Metabolic Effects of Olmesartan

AKYUREK O., Akbal E., Gunes F., Akyurek N.

ARCHIVES OF MEDICAL RESEARCH, vol.45, no.2, pp.138-142, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 45 Issue: 2
  • Publication Date: 2014
  • Doi Number: 10.1016/j.arcmed.2013.12.005
  • Journal Name: ARCHIVES OF MEDICAL RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.138-142
  • Çanakkale Onsekiz Mart University Affiliated: Yes

Abstract

Background and Aims. We undertook this study to investigate the effects of olmesartan treatment on PPAR-gamma (PPAR-gamma) concentrations and metabolic syndrome (MetS) components in hypertensive (HT) patients.